Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beyfortus
Pharma
Sanofi is going all in on Dupixent's next potential nod in COPD
Ahead of an FDA action date this summer, Sanofi is prepping for Dupixent's potential debut in its next "major growth pillar," CEO Paul Hudson said.
Fraiser Kansteiner
Apr 25, 2024 12:37pm
Pfizer plots new RSV filing with positive Abrysvo data in adults
Apr 9, 2024 6:45am
In year 2, Pfizer's RSV vax Abrysvo retains most of its efficacy
Feb 29, 2024 8:02am
Amid supply constraints, Sanofi has big ambitions for Beyfortus
Feb 1, 2024 9:59am
Big Pharma deal spree, China plans and more—Fierce Pharma Asia
Jan 5, 2024 8:44am
China signs off on AZ, Sanofi's RSV shot Beyfortus for infants
Jan 2, 2024 11:27am